ArticleFrontiers in immunology2022

A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection.

Kathrin Endt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.